AACR publications are going mobile! You can now access the full text of AACR journals from your iPhone or iPad. The app provides access to OnlineFirst articles as well as complete journal issues; you can even cache full-text articles for reading offline.

This app includes the following seven journals, published by the AACR:

- CANCER DISCOVERY publishes high-impact articles describing major advances in research and clinical trials. CANCER DISCOVERY is the essential cancer information resource and publishes Review Articles, Perspectives and Commentaries, News, and Research Watch summaries of important journal articles. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies.

- CANCER RESEARCH publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention, and epidemiologic research. CANCER RESEARCH seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The journal’s primary subsections focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.

- CLINICAL CANCER RESEARCH focuses on innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. The journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials and studies of targ
etable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.

- CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION (CEBP) publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; and the science of cancer health disparities.

- MOLECULAR CANCER RESEARCH publishes articles that reflect its focus on the molecular and cellular aspects of cancer biology. The articles should have implications for cancer therapeutics in one of the following areas: angiogenesis, metastasis, and the cellular microenvironment; cancer genes and genomics; cell cycle, cell death, and senescence; DNA damage and cellular stress responses; and signaling and regulation.

- MOLECULAR CANCER THERAPEUTICS publishes the best science in the categories of therapeutic discovery, preclinical development, and molecular medicine in practice.

- CANCER PREVENTION RESEARCH focuses exclusively on cancer prevention. The journal publishes important original studies, reviews, and perspectives within the major topic areas of oncogenesis, risk factors and risk assessment, early detection research, and chemopreventive and other interventions, including the basic science behind them. CaPR comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.